grants_govRFA-RM-27-002
Open
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
- Response deadline
- Aug 17, 2026 Closed
- Date posted
- Jun 26, 2026
- Source
- Open notice
Description
The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.
Classifications
- NAICS93.310
Documents (1)
- DownloadRFA-RM-27-002-Full-Announcement.htmltext/html;charset=UTF-8134 KB
Contacts
Similar contracts
- Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed)Due Jan 8, 2027
- Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)Due Jan 8, 2027
- Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)Due Jan 8, 2027
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)Due Jan 29, 2027
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)Due Nov 23, 2026
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)Due Nov 23, 2026